Zobrazeno 1 - 10
of 17
pro vyhledávání: '"H.-J. M. Brinkman"'
Publikováno v:
Journal of Thrombosis and Haemostasis, 11(6), 1111-1118. Wiley
Summary Background Rivaroxaban has been approved as an antithrombotic agent for prevention of venous thromboembolism with specific indications. At present no antidote is appointed and no guidelines have been formulated for the measurement of Rivaroxa
Autor:
P. G. De Groot, Jan Voorberg, Mariëtte Boon-Spijker, Koen Mertens, I. Dienava-Verdoold, B. de Laat, R. H. W. M. Derksen, H.-J. M. Brinkman
Publikováno v:
Journal of thrombosis and haemostasis, 9(4), 738-747. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 9(4), 738-747. Wiley
Journal of Thrombosis and Haemostasis, 9(4), 738-747. Wiley
Patients with antiphospholipid syndrome (APS) display a heterogeneous population of antibodies with beta(2) glycoprotein-1 (?(2)GP1) as the major antigen.We isolated and characterized human mAbs directed against ?(2)GP1 from the immune repertoire of
Autor:
Sabina Kersting, H.-J. M. Brinkman, Rob Fijnheer, Thalia Romani de Wit, Jan A. van Mourik, Ronald J. Hené
Publikováno v:
British Journal of Haematology. 123:522-527
Summary. It is generally assumed that endothelial cell injury is the primary event in the pathogenesis of thrombotic thrombocytopenic purpura (TTP). In this study, we have determined the extent of vascular perturbation during acute episodes of the di
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 22:511-516
Apparently quiescent, nonapoptotic endothelial cells mediate the activation of factor X by activated factor IX in the presence of its cofactor, activated factor VIII. In a previous study, we reported that during the activation of factor X, the intera
Autor:
Koen Mertens, Alexander B. Meijer, I. Dienava-Verdoold, H.-J. M. Brinkman, Mariëtte Boon-Spijker, Fabian Stavenuiter
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 10(5)
Summary. Background: Factor seven activating protease (FSAP) was initially reported as an activator of single-chain urokinase-type plasminogen activator (scuPA) and factor VII (FVII). Subsequently, numerous additional substrates have been identified,
Autor:
Koen Mertens, K. Grijm, L. Zwart-Huinink, H.-J. M. Brinkman, Joost C. M. Holthuis, J. A. Van Mourik
Publikováno v:
British Journal of Haematology. 87:332-342
Rates of factor X activation on endothelial cells were compared with activation rates on other vascular cells, platelets, monocytes and negatively charged phospholipid vesicles. Factor VIIa-mediated factor X activation was observed on smooth muscle c
Publikováno v:
Thrombosis and Haemostasis. 63:291-297
SummaryWe observed that the growth of human umbilical arterysmooth muscle cells was inhibited by the phospholipase A2 inhibitors p-bromophenacylbromide and mepacrine. Thesefindings suggest that fatty acid metabolism might be integrated in the control
Autor:
Jan A. van Mourik, Rozalia T.M de Laaf, Jan Voorberg, Thalia Romani de Wit, Erica Sellink, Mariska G. Rondaij, Hubert P. J. C. de Leeuw, H.-J. M. Brinkman
Publikováno v:
Experimental cell research, 286(1), 67-74. Academic Press Inc.
Vascular endothelial cells are able to store the chemotactic cytokine interleukin-8 (IL-8) in specialized storage vesicles, Weibel-Palade bodies, together with von Willebrand factor (VWF) and P-selectin. We investigated whether VWF plays a role in th
Autor:
H.-J. M. Brinkman, C. Hop, Hans Pannekoek, Ian R. Peake, Martina E. Daly, Andrea Guilliatt, H. P. J. C. De Leeuw, J. A. Van Mourik
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology, 20(7), 1763-1768. Lippincott Williams and Wilkins
Abstract —We designed a model system to study the role of von Willebrand factor (vWF) in the sorting of P-selectin and the biogenesis of Weibel-Palade body (WPB)–like organelles. For that purpose, a human epithelial cell line (T24) that synthesiz
Publikováno v:
The Biochemical journal. 323
A localized and regulated cascade of proteolytic events is a prerequisite for normal haemostasis. The activation of factor X by activated factor IX (factor IXa) in the presence of activated factor VIII (factor VIIIa) is essential for the formation of